Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NBTY sales jump 73% to $139 mil. on Nutrition Headquarters mail-order addition.

This article was originally published in The Tan Sheet

Executive Summary

NBTY SALES UP 73.2% TO $138.9 MIL. ON NUTRITION HEADQUARTERS ADDITION in April, which was accounted for as a pooling-of- interests merger, Bohemia, N.Y.-based NBTY announced July 28. Net income for the fiscal third quarter (ended June 30) rose 3.9% $8.1 mil. The net income figures include $3.3 mil. in merger-related costs and a gain of $1.6 mil. through the sale of a former division. Consolidated sales through nine months rose 78.1% to $425.8 mil., and net income was up 34.1% to $31.8 mil. for the same period.

You may also be interested in...



NBTY Nutrition Warehouse Acquisition Adds To Direct Mail, Retail Growth

NBTY has reached an agreement to acquire the vitamin and supplement firm Nutrition Warehouse, Inc. for $20 mil. and just over 1 mil. shares of NBTY stock, the company announced Nov. 12.

NBTY Nutrition Warehouse Acquisition Adds To Direct Mail, Retail Growth

NBTY has reached an agreement to acquire the vitamin and supplement firm Nutrition Warehouse, Inc. for $20 mil. and just over 1 mil. shares of NBTY stock, the company announced Nov. 12.

NBTY Nutrition Warehouse Acquisition Adds To Direct Mail, Retail Growth

NBTY has reached an agreement to acquire the vitamin and supplement firm Nutrition Warehouse, Inc. for $20 mil. and just over 1 mil. shares of NBTY stock, the company announced Nov. 12.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS088720

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel